Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Yan TD, Black D, Savady R, Sugarbaker PH.

Ann Surg Oncol. 2007 Feb;14(2):484-92. Epub 2006 Oct 12. Review.

PMID:
17054002
2.
3.

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O; Association Française de Chirurgie.

Eur J Surg Oncol. 2010 May;36(5):456-62. doi: 10.1016/j.ejso.2010.01.006. Epub 2010 Mar 12.

PMID:
20227231
4.
5.

Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.

Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL.

Ann Surg Oncol. 2009 Jul;16(7):1903-11. doi: 10.1245/s10434-009-0341-8. Epub 2009 Apr 23.

PMID:
19387742
6.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

7.

Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.

Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG.

Eur J Surg Oncol. 2012 Oct;38(10):969-76. doi: 10.1016/j.ejso.2012.06.552. Epub 2012 Jul 3.

PMID:
22763244
8.

Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, Dromain C, Duvillard P, Goéré D.

Br J Surg. 2008 Sep;95(9):1164-71. doi: 10.1002/bjs.6235.

PMID:
18690633
9.

Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.

Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O.

Dis Colon Rectum. 2005 Jul;48(7):1372-9.

PMID:
15909071
10.

Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study.

Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC.

Dis Colon Rectum. 2008 Jun;51(6):868-74. doi: 10.1007/s10350-008-9223-6. Epub 2008 Feb 23.

PMID:
18297361
11.

[Literature review of the efficacy and safety of hyperthermic intraperitoneal perfusion chemotherapy after cytoreductive surgery in the treatment of pseudomyxoma peritonei].

Ba MC, Cui SZ, Luo FT, Ouyang WW, Tang YQ, Wu YB, Tang HS.

Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Feb;14(2):132-5. Review. Chinese.

PMID:
21365508
12.

Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Saxena A, Yan TD, Chua TC, Morris DL.

Ann Surg Oncol. 2010 May;17(5):1291-301. doi: 10.1245/s10434-009-0875-9. Epub 2009 Dec 29.

PMID:
20039212
13.

[Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy].

Elias D, Laurent S, Antoun S, Duvillard P, Ducreux M, Pocard M, Lasser P.

Gastroenterol Clin Biol. 2003 Apr;27(4):407-12. French.

14.

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.

Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL.

Br J Surg. 2006 Oct;93(10):1270-6.

PMID:
16838392
15.

Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei.

Butterworth SA, Panton ON, Klaassen DJ, Shah AM, McGregor GI.

Am J Surg. 2002 May;183(5):529-32.

PMID:
12034386
16.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
17.

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results.

Chua TC, Robertson G, Liauw W, Farrell R, Yan TD, Morris DL.

J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45. doi: 10.1007/s00432-009-0667-4. Epub 2009 Aug 23. Review.

PMID:
19701772
18.

Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.

Chua TC, Al-Zahrani A, Saxena A, Liauw W, Zhao J, Morris DL.

J Am Coll Surg. 2010 Oct;211(4):526-35. doi: 10.1016/j.jamcollsurg.2010.06.011. Epub 2010 Aug 21.

PMID:
20729102
19.

Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.

Pestieau SR, Esquivel J, Sugarbaker PH.

Ann Surg Oncol. 2000 Apr;7(3):199-203.

PMID:
10791850
20.

[Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].

Smeenk RM, Verwaal VJ, Zoetmulder FA.

Ned Tijdschr Geneeskd. 2007 Feb 17;151(7):418-23. Dutch.

PMID:
17343142

Supplemental Content

Support Center